BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27681457)

  • 1. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
    Manon-Jensen T; Karsdal MA; Nielsen LN; Kjelgaard-Hansen M; Vandahl B; Olsen EH; Enoksson M; Roepstorff K
    J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The F8(-/-) rat as a model of hemophilic arthropathy.
    Sørensen KR; Roepstorff K; Wiinberg B; Hansen AK; Tranholm M; Nielsen LN; Kjelgaard-Hansen M
    J Thromb Haemost; 2016 Jun; 14(6):1216-25. PubMed ID: 27060449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic vascular basement membrane markers linked to synovial vascular remodeling are biomarkers of hemarthrosis in patients with hemophilia.
    Gopal S; Barnes RFW; Cooke EJ; Zhou JY; Levin I; Emery P; Hughes TH; Karsdal MA; Manon-Jensen T; von Drygalski A
    J Thromb Haemost; 2021 May; 19(5):1200-1211. PubMed ID: 33587779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo.
    van Vulpen LFD; Popov-Celeketic J; van Meegeren MER; Coeleveld K; van Laar JM; Hack CE; Schutgens REG; Mastbergen SC; Lafeber FPJG
    J Thromb Haemost; 2017 Sep; 15(9):1788-1798. PubMed ID: 28696534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice.
    Cooke EJ; Wyseure T; Zhou JY; Gopal S; Nasamran CA; Fisch KM; Manon-Jensen T; Karsdal MA; Mosnier LO; von Drygalski A
    J Thromb Haemost; 2019 Nov; 17(11):1815-1826. PubMed ID: 31301687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological biomarkers in hemophilic arthropathy: Can they be used to monitor bleeding and ongoing progression of blood-induced joint disease in patients with hemophilia?
    Rodriguez-Merchan EC
    Blood Rev; 2020 May; 41():100642. PubMed ID: 31796337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Progression of Hemophilic Arthropathy: The Role of Biomarkers.
    Pasta G; Annunziata S; Polizzi A; Caliogna L; Jannelli E; Minen A; Mosconi M; Benazzo F; Di Minno MND
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?
    Mert L; Bilgiç B; Şenol BK; Zülfikar OB; Durmaz H; Polat G
    Clin Orthop Relat Res; 2023 Aug; 481(8):1634-1647. PubMed ID: 37036937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding.
    Wyseure T; Yang T; Zhou JY; Cooke EJ; Wanko B; Olmer M; Agashe R; Morodomi Y; Behrendt N; Lotz M; Morser J; von Drygalski A; Mosnier LO
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular remodeling underlies rebleeding in hemophilic arthropathy.
    Bhat V; Olmer M; Joshi S; Durden DL; Cramer TJ; Barnes RF; Ball ST; Hughes TH; Silva M; Luck JV; Moore RE; Mosnier LO; von Drygalski A
    Am J Hematol; 2015 Nov; 90(11):1027-35. PubMed ID: 26257191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy.
    Hua B; Olsen EHN; Sun S; Gudme CN; Wang L; Vandahl B; Roepstorff K; Kjelgaard-Hansen M; Sørensen BB; Zhao Y; Karsdal MA; Manon-Jensen T
    Haemophilia; 2017 Jul; 23(4):e294-e300. PubMed ID: 28439941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.
    Haxaire C; Hakobyan N; Pannellini T; Carballo C; McIlwain D; Mak TW; Rodeo S; Acharya S; Li D; Szymonifka J; Song X; Monette S; Srivastava A; Salmon JE; Blobel CP
    Blood; 2018 Sep; 132(10):1064-1074. PubMed ID: 29776906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study.
    van Vulpen LF; van Meegeren ME; Roosendaal G; Jansen NW; van Laar JM; Schutgens RE; Mastbergen SC; Lafeber FP
    Osteoarthritis Cartilage; 2015 Jan; 23(1):63-9. PubMed ID: 25219667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor 1 alpha (SDF-1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy.
    Leuci A; Robert M; Josset L; Marano M; Connes P; Désage S; Meunier S; Lienhart A; Dargaud Y
    Int J Rheum Dis; 2024 Feb; 27(2):e15061. PubMed ID: 38465833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trial.
    Manon-Jensen T; Tangada S; Bager C; Chowdary P; Klamroth R; von Drygalski A; Windyga J; Escobar M; Frederiksen P; Engl W; Ewenstein B; Karsdal M
    J Thromb Haemost; 2024 Jan; 22(1):90-100. PubMed ID: 37717853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of hemophilic arthropathy and potential targets for therapy.
    Pulles AE; Mastbergen SC; Schutgens RE; Lafeber FP; van Vulpen LF
    Pharmacol Res; 2017 Jan; 115():192-199. PubMed ID: 27890816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of miR125a-5p and human Factor VIII attenuates molecular mediators of hemophilic arthropathy.
    Senthilkumar MB; Sarangi P; Amit S; Senguttuvan S; Kumar N; Jayandharan GR
    Thromb Res; 2023 Nov; 231():8-16. PubMed ID: 37741049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.
    Magisetty J; Pendurthi UR; Esmon CT; Rao LVM
    Blood; 2020 Jun; 135(25):2211-2223. PubMed ID: 32294155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of six biomarkers in diagnosis of hemophilic arthropathy: review of the literature.
    Pasta G; Jannelli E; Ivone A; Mosconi M; Ferranti Calderoni E; Minen A; Benazzo F; Rodriguez-Merchan EC
    J Biol Regul Homeost Agents; 2020; 34(3 Suppl. 2):7-13. ADVANCES IN MUSCULOSKELETAL DISEASES AND INFECTIONS - SOTIMI 2019. PubMed ID: 32856434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.